NEOSTIGMINE METHYLSULFATE
Generic: NEOSTIGMINE METHYLSULFATE
BE Pharmaceuticals Inc.Manufacturer
INTRAVENOUSRoute
NEOSTIGMINE METHYLSULFATEActive Substance
2019-05-13Original Approval
NEOSTIGMINE METHYLSULFATE is FDA application ANDA212512, sponsored by BE PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
34 reports
2
ABDOMINAL DISTENSION
25 reports
3
NAUSEA
23 reports
4
HYPOTENSION
22 reports
5
ABDOMINAL PAIN
19 reports
6
RESPIRATORY FAILURE
19 reports
7
WHITE BLOOD CELL COUNT INCREASED
18 reports
8
CARDIAC ARREST
16 reports
9
PYREXIA
16 reports
10
BRADYCARDIA
15 reports